Rheumatoid arthritis and tumor necrosis factor alpha.
Abe
T
T
2nd Department of Internal Medicine, Saitama Medical Center/School, Japan.
Takeuchi
T
T
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000209:etiology* / Q000276:immunology / Q000628:therapy; D006801:Humans; D000069285:Infliximab; D007375:Interleukin-1 / Q000502:physiology; D019409:Interleukin-15 / Q000502:physiology; D020381:Interleukin-17 / Q000502:physiology; D020382:Interleukin-18 / Q000502:physiology; D008727:Methotrexate / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology*
D000911:Antibodies, Monoclonal; D007375:Interleukin-1; D019409:Interleukin-15; D020381:Interleukin-17; D020382:Interleukin-18; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D008727:Methotrexate